The Chemours Company has completed the sale of its clean and disinfect business to Lanxess for approximately $230 million in cash.
 
The clean and disinfect business, with approximately $110 million in combined revenue, is a set of leading oxidation chemistry businesses focused on providing innovative cleaning and disinfection solutions for a wide range of industrial, consumer, animal and human health applications.
 
The disinfectants are marketed for biosecurity applications in the veterinary segment. The core product brand is Virkon S, a powder disinfectant with proven performance against a broad range of viruses, bacteria and fungi. It is used, for example, to combat Foot-and-Mouth disease and Avian Influenza.
 
The second segment focuses on the production and marketing active ingredient potassium monopersulfate with its core brand Oxone. It is used in pool and spa applications, personal hygiene products and electronics applications and as active ingredient in the formulation of disinfection products, especially in Virkon branded products.
 
Thirdly, chlorine dioxide is a proven package solution provider for industrial water treatment applications.
 
“The acquisition is the first milestone on our path of growth and a further step toward strengthening our business in North America,” said Matthias Zachert, chairman of the board of management of Lanxess AG. “The successful integration of the new business now has absolute priority so we can quickly benefit from this expansion of our specialty chemicals portfolio.”
 
The new business is to be integrated into Lanxess’ Material Protection Products business unit, not only expanding its active ingredients portfolio but also extending the value chain in the veterinary disinfection segment through to the end market. The acquired business has three production sites in Memphis and North Kingstown in the US and Sudbury in the United Kingdom. The business comprises three product lines: disinfectants, potassium monopersulfate and chlorine dioxide.